Skip to Content

Pyridostigmine Pregnancy and Breastfeeding Warnings

Pyridostigmine is also known as: Mestinon, Mestinon Timespan, Regonol

Pyridostigmine Pregnancy Warnings

Pyridostigmine has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. At normal doses, pyridostigmine is not expected to significantly cross the placenta. One case of microcephaly has been reported; however, causality was unclear (disease or drug etiology). Pyridostigmine in large doses reportedly crosses the placenta and reduces fetal plasma cholinesterase activity. Parenteral anticholinesterases have been associated with premature labor when administered near term. Pyridostigmine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Pyridostigmine Breastfeeding Warnings

Pyridostigmine is excreted into human milk. Conclusions from limited data (2 patients) have estimated that infants would ingest less than 0.1% of the maternal dose. Adverse effects in the infant are unlikely. Pyridostigmine is considered compatible with breast-feeding by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. Al-Shekhlee A, Robin N, Kaminski HJ "Pyridostigmine-induced microcephaly." Neurology 56 (2001): 1606-7
  2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  3. Niesen CE, Shah NS "Pyridostigmine-induced microcephaly." Neurology 54 (2000): 1873-4

References for breastfeeding information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. Aquilonius S-M, Hartvig P "Clinical pharmacokinetics of cholinesterase inhibitors." Clin Pharmacokinet 11 (1986): 236-49

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.